BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), BCAT1 promotes the clonogenic growth by the reamination of BCKAs to form BCAAs and, thus, activating the mTOR pathway.